Nuo Therapeutics, Inc.
AURX · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $96,980 | $70,235 | $56,179 | $65,543 |
| - Cash | $515 | $316 | $56 | $284 |
| + Debt | $115 | $132 | $148 | $164 |
| Enterprise Value | $96,580 | $70,050 | $56,272 | $65,423 |
| Revenue | $1,032 | $700 | $484 | $395 |
| % Growth | 47.4% | 44.6% | 22.7% | – |
| Gross Profit | $625 | $541 | $363 | $308 |
| % Margin | 60.6% | 77.2% | 75% | 78.1% |
| EBITDA | -$496 | -$611 | -$745 | -$601 |
| % Margin | -48.1% | -87.3% | -153.8% | -152.2% |
| Net Income | -$538 | -$650 | -$746 | -$497 |
| % Margin | -52.1% | -92.8% | -154% | -125.8% |
| EPS Diluted | -0.01 | -0.014 | -0.016 | -0.011 |
| % Growth | 28.1% | 12.6% | -50% | – |
| Operating Cash Flow | -$707 | $262 | $2 | -$491 |
| Capital Expenditures | $0 | -$2 | -$230 | $0 |
| Free Cash Flow | -$707 | $261 | -$228 | -$491 |